6660 — AIM Vaccine Co Balance Sheet
0.000.00%
- HK$4.81bn
- HK$6.57bn
- CNY1.29bn
- 13
- 25
- 49
- 15
Annual balance sheet for AIM Vaccine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,103 | 747 | 798 | 736 | 595 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 957 | 1,091 | 1,096 | 1,080 | 1,183 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,438 | 2,359 | 2,549 | 2,483 | 2,387 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,635 | 3,020 | 3,603 | 3,604 | 3,553 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,688 | 8,072 | 8,876 | 7,262 | 7,314 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,131 | 1,570 | 2,250 | 2,602 | 3,090 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,266 | 3,180 | 3,916 | 3,619 | 3,949 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3,422 | 4,893 | 4,960 | 3,643 | 3,366 |
| Total Liabilities & Shareholders' Equity | 4,688 | 8,072 | 8,876 | 7,262 | 7,314 |
| Total Common Shares Outstanding |